James L. Tyree, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 12,705 shares at $52.83 ($669K) on 2007-02-15, disclosed to the SEC on 2007-02-20.
Scheduled sale ($669k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.70 | 5,260 | $277K | 41.5% |
| 2 | $52.83 | 1,500 | $79K | 11.9% |
| 3 | $52.49 | 3,486 | $183K | 27.4% |
| 4 | $52.49 | 683 | $36K | 5.4% |
| 5 | $52.49 | 1,776 | $93K | 13.9% |
| Total | $52.62 avg | 12,705 |
| $669K |
| 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |